Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Efstathiou

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancerNeeraj Agarwal, Tian Zhang, Eleni Efstathiou, et al.
BMC Medical Genomics|August 6, 2009
Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression dataIvan P Gorlov, Jinyoung Byun, Olga Y Gorlova, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|November 27, 2012
Bartonella quintana endocarditis as a cause of severe aortic insufficiency and heart failureStavros Dimopoulos, Evagelos Eleftherakis, Christos Charitos, et al.
Gynecologic Oncology|October 21, 2006
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinomaGeorge Bozas, Aristotle Bamias, Vassiliki Koutsoukou, et al.
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2021
Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostateWan-Fu Wu, Li Wang, Nicholas Spetsieris, et al.
European Urology|February 21, 2015
Long-term Safety and Antitumor Activity in the Phase 1-2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate CancerCelestia S Higano, Tomasz M Beer, Mary-Ellen Taplin, et al.
Cancer|April 28, 2005
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacinGeorgios Chamilos, Aristotle Bamias, Eleni Efstathiou, et al.
Cancer Genetics and Cytogenetics|May 30, 2002
A change in the last base of BRCA1 exon 23, 5586G-->A, results in abnormal RNA splicingAngela Ladopoulou, Irene Konstantopoulou, Sofia Armaou, et al.
Urology|September 8, 2004
Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology GroupHelena Linardou, Gerassimos Aravantinos, Eleni Efstathiou, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancerNeeraj Agarwal, Tian Zhang, Eleni Efstathiou, et al.
BMC Medical Genomics|August 6, 2009
Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression dataIvan P Gorlov, Jinyoung Byun, Olga Y Gorlova, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|November 27, 2012
Bartonella quintana endocarditis as a cause of severe aortic insufficiency and heart failureStavros Dimopoulos, Evagelos Eleftherakis, Christos Charitos, et al.
Gynecologic Oncology|October 21, 2006
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinomaGeorge Bozas, Aristotle Bamias, Vassiliki Koutsoukou, et al.
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2021
Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostateWan-Fu Wu, Li Wang, Nicholas Spetsieris, et al.
European Urology|February 21, 2015
Long-term Safety and Antitumor Activity in the Phase 1-2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate CancerCelestia S Higano, Tomasz M Beer, Mary-Ellen Taplin, et al.
Cancer|April 28, 2005
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacinGeorgios Chamilos, Aristotle Bamias, Eleni Efstathiou, et al.
Cancer Genetics and Cytogenetics|May 30, 2002
A change in the last base of BRCA1 exon 23, 5586G-->A, results in abnormal RNA splicingAngela Ladopoulou, Irene Konstantopoulou, Sofia Armaou, et al.
Urology|September 8, 2004
Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology GroupHelena Linardou, Gerassimos Aravantinos, Eleni Efstathiou, et al.
Pageof 15